+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Bladder Cancer Drugs Market Research Reports

Bladder Cancer Drugs Global Market Report 2024 - Product Thumbnail Image

Bladder Cancer Drugs Global Market Report 2024

  • Report
  • November 2023
  • 175 Pages
  • Global
From
Bladder Cancer Therapeutics: Global Strategic Business Report - Product Thumbnail Image

Bladder Cancer Therapeutics: Global Strategic Business Report

  • Report
  • March 2024
  • 283 Pages
  • Global
From
Doxorubicin Global Market Report 2024 - Product Thumbnail Image

Doxorubicin Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Urinary Tract Cancer Global Market Report 2024 - Product Thumbnail Image

Urinary Tract Cancer Global Market Report 2024

  • Report
  • January 2024
  • 175 Pages
  • Global
From
Urothelial Carcinoma Treatment Global Market Report 2024 - Product Thumbnail Image

Urothelial Carcinoma Treatment Global Market Report 2024

  • Report
  • January 2024
  • 175 Pages
  • Global
From
Doxorubicin - Global Strategic Business Report - Product Thumbnail Image

Doxorubicin - Global Strategic Business Report

  • Report
  • March 2024
  • 288 Pages
  • Global
From
From
From
From
From
From
Pemetrexed + cisplatin Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

Pemetrexed + cisplatin Drug Insight and Market Forecast - 2032

  • Report
  • November 2023
  • 30 Pages
  • Global
From
IMFINZI Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

IMFINZI Emerging Drug Insight and Market Forecast - 2032

  • Report
  • November 2023
  • 30 Pages
  • Global
From
Non Muscle Invasive Bladder Cancer - Pipeline Insight, 2023 - Product Thumbnail Image

Non Muscle Invasive Bladder Cancer - Pipeline Insight, 2023

  • Clinical Trials
  • July 2023
  • 80 Pages
  • Global
From
Loading Indicator

The Bladder Cancer Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs used to treat bladder cancer. Bladder cancer is a type of cancer that affects the urinary tract and is the sixth most common type of cancer in the United States. Common treatments for bladder cancer include chemotherapy, radiation therapy, and surgery. Drugs used to treat bladder cancer are typically classified as either targeted therapies or immunotherapies. Targeted therapies are designed to target specific molecules or pathways in the body that are involved in the growth and spread of cancer cells. Immunotherapies are designed to stimulate the body’s own immune system to fight cancer cells. Some of the major companies in the Bladder Cancer Drugs market include AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are involved in the development and sale of drugs used to treat bladder cancer. Show Less Read more